Security Snapshot

Aprea Therapeutics, Inc. - Common Stock (APRE) Institutional Ownership

CUSIP: 03836J201

13F Institutional Holders and Ownership History from Q1 2023 to Q2 2026

Latest Period

Q2 2026

Institutions Reporting

28

Shares (Excl. Options)

2,370,855

Price

$0.80

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Security type / class
Equity / Common Stock
Symbol
APRE on Nasdaq
All holders as of 30 Jun 2026
Q2 2026
Total 13F shares
2,370,855
Latest holder snapshot 5 signals
Total 13F value
$1,902,120
Portfolio coverage rank
0%
Share change
+121,151
Value change
+$100,392
Number of holders
28
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
12,212,719
SEC-reported price per share
$0.62
Insider filing price
$0.62
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • APRE - Aprea Therapeutics, Inc. - Common Stock is tracked under CUSIP 03836J201.
  • 28 institutions reported positions in Q2 2026.
  • 4 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 22 to 28 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from $1,712,195 to $1,902,120.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 28 institutions filings for Q2 2026.

Open SEC evidence

Security key

03836J201

Latest holder period

Q2 2026

13F holders

28

13D/G owners

4

CIK / CUSIP context first

Open Q2 2026 holders APRE full holder history Aprea Therapeutics, Inc. SEC filings Aprea Therapeutics, Inc. company facts Aprea Therapeutics, Inc. insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
4
Security
APRE
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Nantahala Capital Management, LLC 4.5% -40% $386,829 411,520 0% Nantahala Capital Management, LLC 31 Dec 2025
LYTTON LAURENCE W 3.2% -67% $293,105 -$218,272 390,807 -43% LYTTON LAURENCE W 30 Jun 2026
Stonepine Capital Management, LLC 4.3% -16% $418,978 -$82,213 239,416 -16% Stonepine Capital Management, LLC 31 Mar 2025
Sio Capital Management, LLC 1.9% -62% $165,529 -$246,540 112,223 -60% Sio Capital Management, LLC 30 Sep 2025

As of 30 Jun 2026, 28 institutional investors reported holding 2,370,855 shares of Aprea Therapeutics, Inc. - Common Stock (APRE). This represents 19% of the company’s total 12,212,719 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
19%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
AIGH Capital Management LLC 8.3% 1,015,541 0% 0.07% $814,768
Vestal Point Capital, LP 2.9% 350,000 0% 0.01% $280,805
SPHERA FUNDS MANAGEMENT LTD. 2.2% 270,000 0% 0.03% $216,621
Nantahala Capital Management, LLC 1.7% 205,760 0% 0.01% $165,081
RENAISSANCE TECHNOLOGIES LLC 0.87% 105,800 +322% 0% $84,883
GEODE CAPITAL MANAGEMENT, LLC 0.61% 74,869 -37% 0% $60,072
CITADEL ADVISORS LLC 0.48% 58,600 0% $47,015
BNP PARIBAS FINANCIAL MARKETS 0.37% 45,211 0% 0% $36,273
DIADEMA PARTNERS LP 0.37% 44,907 0.01% $36,029
VANGUARD FIDUCIARY TRUST CO 0.31% 38,464 0% 0% $30,848
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.29% 34,939 +168% 0% $28,032
MORGAN STANLEY 0.21% 25,830 +16% 0% $20,723
VANGUARD CAPITAL MANAGEMENT LLC 0.19% 22,882 +17% 0% $18,351
LPL Financial LLC 0.13% 16,052 -24% 0% $12,879
HighTower Advisors, LLC 0.11% 13,864 0% 0% $11,123
NORTHERN TRUST CORP 0.11% 13,705 0% $10,996
Persistent Asset Partners Ltd 0.09% 11,490 0% $9,218
XTX Topco Ltd 0.09% 10,565 0% $8,476
BlackRock, Inc. 0.06% 7,173 -16% 0% $5,755
Tower Research Capital LLC (TRC) 0.03% 3,590 -30% 0% $2,880
GROUP ONE TRADING LLC 0% 577 0% 0% $463
BARCLAYS PLC 0% 473 0% $379
OSAIC HOLDINGS, INC. 0% 295 0% 0% $236
WealthCollab, LLC 0% 158 0% 0% $127
Integrated Wealth Concepts LLC 0% 46 0% $36

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
14
Latest
Q2 2026
Rows shown
1-14 of 14
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q2 2,370,855 $1,902,120 +$100,392 $0.80 28
2026 Q1 2,244,310 $1,712,195 +$356,352 $0.76 22
2025 Q4 1,695,512 $1,446,275 -$113,007 $0.85 22
2025 Q3 1,618,851 $2,387,744 -$296,033 $1.48 23
2025 Q2 1,815,508 $3,072,270 -$77,601 $1.69 23
2025 Q1 1,847,462 $3,768,839 -$165,845 $2.04 25
2024 Q4 2,077,381 $6,829,282 +$211,103 $3.29 26
2024 Q3 2,000,189 $5,500,414 -$431,314 $2.75 21
2024 Q2 2,083,045 $8,477,419 +$1,866,030 $4.07 27
2024 Q1 1,624,394 $10,764,195 +$4,966,764 $6.69 22
2023 Q4 926,780 $4,355,977 +$26,645 $4.70 19
2023 Q3 876,935 $3,660,270 -$19,509 $4.17 19
2023 Q2 881,553 $2,776,892 +$105,033 $3.15 17
2023 Q1 848,237 $3,769,266 +$3,769,266 $4.44 15
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .